ToolAssay

Upcoming biotech clinical-trial catalysts (?ticker=<biotech ticker> or ?company=

Upcoming biotech clinical-trial catalysts (?ticker=<biotech ticker> or ?company=)

Answeringour last check, 2026-09-24
1 of 1checks answered this week
875 msmedian answer time
$0.05listed price per call
$0.05price it asked us

Paid test badge: not yet. The checks above are free: we call the tool without paying and read the payment request it sends back. The Verified badge needs paid calls whose answers match the promised output, and nobody can buy a badge.

Endpoint

GET https://pharma.lonestaroracle.xyz/catalysts

CategoryCompany and compliance
Provider hostpharma.lonestaroracle.xyz
Networkseip155:8453, solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp
Payment schemesexact
Self-reported calls, 30 days3 from 1 payers (the provider's figure, not ours)

Our checks, last 30 days

DayResultHTTPAskedTime
2026-09-24 valid payment request 402$0.05 875 ms

Example input (from the provider)

{
  "method": "GET",
  "queryParams": {
    "company": "NVIDIA",
    "days": 365,
    "ticker": "SRPT"
  },
  "type": "http"
}

Promised output schema (from the provider)

{
  "category": "markets",
  "description": "Biotech catalyst tracking made agent-callable. One x402 call takes a stock ticker (or company name) and returns a catalyst signal (HIGH / MODERATE / LOW / NONE) plus the company's upcoming late-stage clinical-trial readouts \u2014 the binary events that move biotech stocks 50-90% in a day. Each catalyst names the phase (2 or 3), the indication, the expected primary-completion date (the data-release proxy), how many days out it is, the trial status and the ClinicalTrials.gov NCT id. The biotech analog of an earnings calendar, served pay-per-call: a trading, research or risk agent asks 'what's coming for $SRPT' and gets the readout schedule. $0.05 in USDC on Base via x402. Sources: ClinicalTrials.gov API v2 (official) + yfinance for ticker resolution (all free/public). NOTE: this is the trial-readout leg \u2014 it does NOT include curated FDA PDUFA decision dates (no free feed exists for those). Companion to EquityScope, OptionsFlow, AnalystEdge and EarningsCalendar.",
  "name": "PharmaCatalyst",
  "properties": {
    "input": {
      "properties": {
        "method": {
          "enum": [
            "GET",
            "HEAD",
            "DELETE"
          ],
          "type": "string"
        },
        "queryParams": {
          "properties": {
            "company": {
              "description": "Company name instead of a ticker (e.g. 'Vertex Pharmaceuticals'). Alias: name.",
              "type": "string"
            },
            "days": {
              "default": 365,
              "description": "Look-ahead horizon in days (default 365, max 1095). Alias: horizon.",
              "type": "integer"
            },
            "ticker": {
              "description": "Biotech stock ticker (e.g. SRPT, VRTX, MRNA). Resolved to a company via yfinance. Alias: symbol.",
              "example": "SRPT",
              "type": "string"
            }
          },
          "type": "object"
        },
        "type": {
          "const": "http",
          "type": "string"
        }
      },
      "required": [
        "type",
        "method"
      ],
      "type": "object"
    },
    "output": {
      "properties": {
        "example": {
          "catalyst_signal": "HIGH",
          "company": "Sarepta Therapeutics, Inc.",
          "counts": {
            "next_90d": 1,
            "phase2": 0,
            "phase3": 2,
            "total_upcoming": 2
          },
          "horizon_days": 365,
          "interpretation": "Near-term binary catalyst risk: a Phase 3 readout (or several trials) due within 90 days.",
          "match": "sponsor",
          "source": "ClinicalTrials.gov API v2",
          "sponsor_query": "Sarepta",
          "ticker": "SRPT",
          "upcoming_catalysts": [
            {
              "days_out": 84,
              "expected_readout": "2026-10-31",
              "indication": "Muscular Dystrophy, Duchenne",
              "lead_sponsor": "Sarepta Therapeutics, Inc.",
              "nct_id": "NCT03992430",
              "phase": "Phase 3",
              "source": "ClinicalTrials.gov",
              "status": "Recruiting",
              "type": "Trial Readout"
            }
          ]
        },
        "type": {
          "type": "string"
        }
      },
      "required": [
        "type"
      ],
      "type": "object"
    }
  },
  "required": [
    "input"
  ],
  "tags": [
    "biotech",
    "pharma",
    "catalyst",
    "clinical-trials",
    "healthcare"
  ],
  "type": "object",
  "version": "1.0.0"
}

This page as JSON